Product Information
NEVIRAPINE 200 MG TABLET is a generic product labeled by Camber Pharmaceuticals Inc., priced at $0.1469 per EA under NDC 31722050560. Its NADAC has been published 496 times since Nov 28, 2013.
FDA first approved this application on May 22, 2012. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
200 mg/1
Manufacturer
Camber Pharmaceuticals Inc.NDC
31722050560
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
NEVIRAPINEApproval Type
Generic (ANDA)
FDA Application
ANDA078584FDA Approved
5/22/2012
TE Code
AB
On Market Since
5/23/2012
Pharmacological Classes
Price Statistics
The NADAC for NEVIRAPINE 200 MG TABLET has been published 496 times since Nov 28, 2013, and over the history we have for it it has declined 20.3%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1469 per EA |
|---|---|
| All-time high | $0.2469 (Sep 13, 2017) |
| All-time low | $0.1122 (Jul 17, 2024) |
| 52-week high | $0.1528 |
| 52-week low | $0.1314 |
| Median price | $0.1507 |
| Average price | $0.1504 |
| Largest weekly change | +45.1% (Jul 18, 2018) |
| Weeks tracked | 496 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
The matcher finds 3 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 10% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of NEVIRAPINE 200 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for NEVIRAPINE 200 MG TABLET, manufactured by Camber Pharmaceuticals Inc., is $0.1469 per EA (NDC 31722050560), effective Aug 19, 2026.
How has the price of NEVIRAPINE 200 MG TABLET changed over time?
Over the history we have for it, the NADAC for NEVIRAPINE 200 MG TABLET has declined 20.3%. It has been tracked across 496 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for NEVIRAPINE 200 MG TABLET?
Since Nov 28, 2013, the NADAC for NEVIRAPINE 200 MG TABLET has ranged from a low of $0.1122 (Jul 17, 2024) to a high of $0.2469 (Sep 13, 2017), with a median of $0.1507 per EA.
Are there cheaper alternatives to NEVIRAPINE 200 MG TABLET?
Yes. 3 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, NEVIRAPINE 200 MG TABLET, is $0.1314 per EA — about 10% below NEVIRAPINE 200 MG TABLET.
Who manufactures NEVIRAPINE 200 MG TABLET?
NEVIRAPINE 200 MG TABLET (NDC 31722050560) is labeled by Camber Pharmaceuticals Inc., and CMS classifies it as a generic product.